New directions for TEC Edmonton client KMT Hepatech

The legendary stories in Edmonton’s medical research circles are about the ones that got away.

The breast cancer vaccine drug Biomira, Isotechnika’s anti-rejection drug, BioMS Medical’s promising cure for multiple sclerosis: All were products of the fertile minds of University of Alberta medical researchers.  All came close to the brass ring. As publicly traded companies, billions […]

By |March 8th, 2016|Innovation Community, TEC Clients|0 Comments

Financing Start-Up Biotechnology Companies

Brian Bloom will be discussing the new realities of financing early stage biotechnology companies. Brian Bloom is the Co-founder and President of Bloom Burton, a company dedicated exclusively to the healthcare investment industry for more than a decade and the premier Canadian biotech investment firm.

By |May 29th, 2015|0 Comments